Examples of 'anti-angiogenic agent' in a sentence
Meaning of "anti-angiogenic agent"
Anti-angiogenic agent: A substance that inhibits the development of new blood vessels. They are often used in cancer treatment to reduce the blood supply to tumors, preventing their growth and spread
How to use "anti-angiogenic agent" in a sentence
Basic
Advanced
anti-angiogenic agent
Methods of inducing responsiveness to anti-angiogenic agent.
Most preferably said anti-angiogenic agent is sunitinib or imatinib.
The antibody is administered with an anti-angiogenic agent.
The anti-angiogenic agent is electrostatically bonded to the polymer of beads.
The microspheres may comprise an anti-angiogenic agent.
More preferably the anti-angiogenic agent is sunitinib and imatinib.
The antibody may be administered with an anti-angiogenic agent.
The anti-angiogenic agent inhibited the tumor growth completely.
In a specific embodiment of the invention, an anti-angiogenic agent is endostatin.
The active anti-angiogenic agent can be formulated in unit dosage form.
In preferred cases a second therapeutic agent is an anti-angiogenic agent.
The adverse systemic side effects of anti-angiogenic agent administration should be avoided.
In preferred embodiments, the additional therapeutic agent is an anti-angiogenic agent.
The anti-angiogenic agent appears to inhibit or prevent angiogenesis by inhibiting or controlling apoptosis.
Another aspect of the invention is said pharmaceutical composition as anti-angiogenic agent.
See also
In one embodiment, the anti-angiogenic agent can be prepared using rational polypeptide design.
In certain embodiments, the small molecule is a cytotoxic or chemotherapeutic or anti-angiogenic agent.
This isoform therefore appears to be an endogenous anti-angiogenic agent formed by differential splicing.
Also, additional anti-angiogenic agent may be included in the delivery system or directly injected.
The invention further provides cationic liposomes containing a taxane as anti-angiogenic agent.
It is important that the anti-angiogenic agent is not covalently attached to the polymer matrix.
The solution is gently shaken until the complete dissolution of the anti-angiogenic agent.
Such an anti-inflammatory agent or anti-angiogenic agent is selected from among those disclosed above.
Equally, the administered antibody may be operatively associated with a second anti-angiogenic agent.
The observations indicated that the effects of anti-angiogenic agent were endothelial cell specific.
Similarly, the administered antibody may be operatively associated with a second anti-angiogenic agent.
One specific embodiment also provides use of an anti-angiogenic agent a wide variety of surgical procedures.
The administered antibody may alternatively be operatively associated with a second anti-angiogenic agent.
The results indicated that anti-angiogenic agent and have specific effects on tumor angiogensis.
In the present invention, the corneal micropocket assay is used to identify an anti-angiogenic agent.
When administered sequentially either the anti-angiogenic agent or the anti-hypertensive agent may be administered first.
The administered antibody may also be operatively associated with a second anti-angiogenic agent.
In another embodiment the anti-angiogenic agent is an inhibitor of the PDGF receptor.
In still another embodiment, the present invention encompasses polyvinylalcohol microspheres further comprising an anti-angiogenic agent.
In another embodiment of the invention, an anti-angiogenic agent is antithrombin III.
In another embodiment, the present invention provides crosslinked polyvinylalcohol microspheres further comprising an anti-angiogenic agent.
In one embodiment the anti-angiogenic agent is an inhibitor of the VEGF receptor.
In one embodiment, the antibody or Fc fusión is administered with an anti-angiogenic agent.
There is currently a protein anti-angiogenic agent approved by the FDA for clinical use.
In one embodiment, the antibody is administered with an anti-angiogenic agent.
Preferably the anti-angiogenic agent is a VEGF or PLGF antagonist.
In one embodiment, the IgG is administered with an anti-angiogenic agent.
Preferably, said anti-angiogenic agent is sunitinib or imatinib.
The chemoembolization composition of claim 8, wherein said anti-angiogenic agent is imatinib.
The anti-angiogenic agent can be naturally occurring or non-naturally occurring.
In some embodiments, the anti-angiogenic agent is bevacizumab.
One may also co-administer an EGFR-targeted drug or an anti-angiogenic agent.
In certain embodiments, an anti-angiogenic agent is a TNF-a antagonist.
In one embodiment of the invention, anti-cancer agent or therapeutic is an anti-angiogenic agent.
In a preferred embodiment, the anti-angiogenic agent is thalidomide.
You'll also be interested in:
Examples of using Anti-angiogenic
Show more
It is anti-angiogenic and also acts as an immunomodulator
Piperine also possesses anti-angiogenic activities
Anti-angiogenic functional and medicinal foods
Examples of using Agent
Show more
Another good agent going down a bad path
Agent detection versus exposure host response
That might get agent sanburg a medal
